Possible Immuno-Modulatory Effect of Tocilizumab in Patients With Refractory Status Epilepticus.

NCT05346666 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Tocilizumab Prefilled Syringe [Actemra]. propofole, phenobarbital, midazolam

Sponsor

Damanhour University

Collaborators

[object Object]
[object Object]